Prevention & care

Heart failure: pumping, filling, ejection fraction, tests, and care goals

8 sources · Latest source check 2026-10-20 UTC

On this page

Heart failure is a condition in which the heart cannot supply blood adequately for the body’s needs. Difficulty filling and difficulty pumping are possible contributors. The name does not mean the heart has stopped. It can develop suddenly or over time, and one or both sides can be affected.[1]

Four ejection-fraction categories, with a history attached

The 2022 US framework uses reduced EF at forty percent or lower, mildly reduced at forty-one to forty-nine percent, and preserved at fifty percent or higher. Improved EF means a previous value at forty percent or lower followed by a value above forty percent. These categories classify an established clinical condition; a preserved percentage alone neither proves nor rules out heart failure.[6]

A pumping percentage is one part of the picture

A pumping percentage is one part of the picture
Term	What it explains
Ejection fraction	The proportion of blood in the left ventricle pumped out with each beat. It is not the percentage of the heart that is alive.[2]
Reduced ejection fraction	The heart ejects a smaller proportion; imaging helps classify the condition and guide care.[2]
Preserved ejection fraction	Heart failure can occur despite a preserved pumping percentage; the full clinical and structural picture matters.[3]
Congestion	Fluid accumulation can accompany heart failure, including swelling or breathing difficulty.[1]

Symptoms and cause both need investigation

Breathlessness, fatigue and swelling can occur in heart failure. Symptoms may appear with activity or when lying down, and the pattern can change. These observations do not identify the cause by themselves. A record of onset, changes and medicines helps the assessment.[2]

Possible causes include coronary disease, high blood pressure, heart-muscle or valve disease and rhythm problems. A condition damaging the heart and the resulting failure of function are related but different labels. Treating a contributing cause can be part of care.[1]

Blood markers, imaging, and electrical tests answer different questions

An echocardiogram uses ultrasound to assess the heart and estimate ejection fraction. Blood tests may measure natriuretic peptides and check kidney or liver function. An ECG records electrical activity; it is different from a scan of pumping function. Assessment combines results with history and examination.[2]

NICE notes that natriuretic-peptide levels do not distinguish reduced, mildly reduced and preserved ejection-fraction types. Other health factors can affect these markers. A raised value is therefore not a complete diagnosis or a treatment instruction.[3]

Relieving fluid and protecting future health are different jobs

Diuretics help remove excess fluid. Other medicines affect blood vessels, heart rate or signalling systems. These are different treatment roles; a symptom improvement does not establish that every future risk has been removed. Blood pressure, kidney function and electrolytes can constrain treatment.[4]

The September 2025 NICE update recommends combinations of medicine classes for reduced ejection fraction and considers selected treatments for mildly reduced or preserved ejection fraction. SGLT2 inhibitors feature in this guidance. The recommendations differ by type, tolerance and clinical context; this is not one universal drug list.[3]

Rehabilitation and procedures have particular purposes

NHLBI describes appropriate activity and cardiac rehabilitation as parts of care, with the activity level adapted to severity. Support can include exercise, education, nutrition, smoking cessation, sleep and emotional wellbeing. A rehabilitation plan supports participation rather than supplying blanket clearance for every activity.[4]

Selected people need procedures for damaged valves or coronary arteries, or implanted devices for rhythm problems. More advanced support may be considered in severe disease. A pacemaker, defibrillator and operation are not interchangeable categories, and each has specific goals and burdens.[5]

A practical plan avoids universal restriction rules

NICE does not advise routine sodium or fluid restriction for everyone with heart failure. It describes selected reasons to adjust intake and ongoing review. The same guidance warns about potassium-containing salt substitutes. A generic wellness instruction can therefore conflict with a person’s clinical plan.[3]

Follow-up should explain which changes to report, who to contact and how care will be reviewed. NHS guidance identifies severe breathing difficulty or someone becoming unresponsive as emergencies. New or worsening symptoms should be assessed through the appropriate local service, rather than attributed automatically to known heart failure.[5]

A combined outcome is not the same as each outcome improving separately

DELIVER randomized 6,263 people with heart failure and EF above forty percent to dapagliflozin or placebo alongside usual care. Over a median 2.3 years, worsening heart failure or cardiovascular death occurred in 16.4% versus 19.5%. The separate cardiovascular-death estimate had a confidence interval that crossed no difference. It is therefore more accurate to report the supported composite benefit than claim the trial independently proved a mortality benefit.[7]

The trial included people with and without diabetes, but it did not select a regimen for every patient with swelling or breathlessness. An observed improvement in EF is also different from a permanent cure. The US guideline recommends continuing appropriate therapy in improved EF because recurrence can occur; changes depend on clinical review, tolerance and individual circumstances.[6]

Early review links medicine changes with safety checks

After an acute heart-failure admission, a care pathway can link medicine adjustment with symptom review, examination and laboratory safety checks. Ask who arranges the visits and tests and how concerns reach the team. The evidence below tests an organized package.[8]

Evidence & uncertainty

Care depends on the type, symptoms, cause and other health conditions. Treatments can ease symptoms and help prevent worsening, but a broad description cannot choose an individual regimen. Newer guidance and older patient explanations also have different dates; the 2025 NICE update is identified below.[5]

Selected-source overview · Independent review pending

Published questions

Does heart failure mean the heart has stopped?

Selected-source overview · Independent review pending. Read the evidence context.

The term describes inadequate heart function; it is different from cardiac arrest.[1]

Evidence behind this answer

What Is Heart Failure?
agency condition explanation · 2022
Selected relevant official page passages inspected · Definition, filling/pumping, congestion, acute/chronic course and causes